Brief: Aligos Therapeutics Enters Settlement Agreement With Janssen Biotech
18/10/2023 13:56
Oct 18 (Reuters) - Aligos Therapeutics Inc ALGS.O :
* ALIGOS THERAPEUTICS INC - ON OCTOBER 16, CO ENTERED
SETTLEMENT
AGREEMENT WITH JANSSEN BIOTECH, INC
* ALIGOS THERAPEUTICS -AGREEMENT PROVIDES FOR RESOLUTION OF
ACTION
BROUGHT BY JANSSEN ALLEGING BREACH OF CONTRACT BY CEO,CHAIRMAN
OF BOARD OF CO,OTHERS
* ALIGOS THERAPEUTICS - PURSUANT TO SETTLEMENT AGREEMENT,
JANSSEN
AGREED TO DISMISS ACTION BROUGHT BY JANSSEN ALLEGING BREACH OF
CONTRACT
* ALIGOS THERAPEUTICS: PURSUANT TO SETTLEMENT, CO AGREED TO
DISMISS COUNTERCLAIMS AGAINST JANSSEN ALLEGING "UNFAIR
COMPETITION"
Further company coverage: ALGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aligos Therapeutics
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
U.S. RESEARCH ROUNDUP-Ciena Corp, Docusign, Snowflake
Brief: Aligos Therapeutics Announces First Participant Dosed In The Phase 1 Study Of Its Potentially Best-In-Class Antisense Oligonucleotide Alg-170675 By Its Partner Amoytop In China
Aligos Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Aligos Therapeutics Q2 net loss narrows on licensing revenue